The trypanosome lytic factor of human serum and the molecular basis of sleeping sickness

International Journal for Parasitology

Volumn 34, Issue 8, 2004, Pages 887-898

  Vanhamme, Luc ^a   Pays, Etienne ^a  

^a FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

Apolipoprotein L I; Haptoglobin related protein; Lysosome; Serum resistance associated protein; Trypanosoma brucei; Trypanosome lytic factor

Indexed keywords

AMMONIUM CHLORIDE; ANTIOXIDANT; APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN L 1; CHLOROQUINE; DNA; HAPTOGLOBIN; HIGH DENSITY LIPOPROTEIN; TRYPANOSOME LYTIC FACTOR 1; TRYPANOSOME LYTIC FACTOR 2; UNCLASSIFIED DRUG;

PARASITOLOGY;

AFRICAN TRYPANOSOMIASIS; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL MEMBRANE; ENDOCYTOSIS; HUMAN; LYSOSOME; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; RNA INTERFERENCE; SCHIZOPHRENIA; SERUM; TANGIER DISEASE; TRANSGENIC MOUSE; TRYPANOSOMA; TRYPANOSOMA BRUCEI; TRYPANOSOMA RHODESIENSE;

MAMMALIA; TRYPANOSOMA; TRYPANOSOMA BRUCEI; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMA BRUCEI RHODESIENSE;

EID: 3042660680     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2004.04.008     Document Type: Review

References (80)

1. Barker C., Barbour K.W., Berger F.G., Hajduk S.L. Activity of human trypanosome lytic factor in mice. Mol. Biochem. Parasitol. 117:2001;129-136
2. Bishop J.R., Shimamura M., Hajduk S.L. Insight into the mechanism of trypanosome lytic factor-1 killing of Trypanosoma brucei brucei. Mol. Biochem. Parasitol. 118:2001;33-40
3. Borst P., Ulbert S. Control of VSG gene expression sites. Mol. Biochem. Parasitol. 114:2001;17-27
4. Brun R., Jenni L. Human serum resistance of metacyclic forms of Trypanosoma brucei brucei, T. brucei rhodesiense and T. brucei gambiense. Parasitol. Res. 73:1987;218-223
5. Campillo N., Carrington M. The origin of the serum resistance associated (SRA) gene and a model of the structure of the SRA polypeptide from Trypanosoma brucei rhodesiense. Mol. Biochem. Parasitol. 127:2003;79-84
6. De Greef C., Hamers R. The serum resistance-associated (SRA) gene of Trypanosoma brucei rhodesiense encodes a variant surface glycoprotein-like protein. Mol. Biochem. Parasitol. 68:1994;277-284
7. De Greef C., Imberechts H., Matthyssens G., Van Meirvenne N., Hamers R. A gene expressed only in serum-resistant variants of Trypanosoma brucei rhodesiense. Mol. Biochem. Parasitol. 36:1989;169-176
8. De Greef C., Chimfwembe E., Kihang'a Wabacha J., Bajyana Songa E., Hamers R. Only the serum-resistant bloodstream forms of Trypanosoma brucei rhodesiense express the serum resistance associated (SRA) protein. Ann. Soc. Belg. Med. Trop. 72:(Suppl. 1):1992;13-21
9. Donelson J.E. Antigenic variation and the African trypanosome genome. Acta Trop. 85:2003;391-404
10. Drain J., Bishop J.R., Hajduk S.L. Haptoglobin-related protein mediates trypanosome lytic factor binding to trypanosomes. J. Biol. Chem. 276:2001;30254-30260
11. Duchateau P.N., Pullinger C.R., Orellana R.E., Kunitake S.T., Naya-Vigne J., O'Connor P.M., Malloy M.J., Kane J.P., Apolipoprotein L. a new human high density lipoprotein apolipoprotein expressed by the pancreas. Identification, cloning, characterization, and plasma distribution of apolipoprotein L. J. Biol. Chem. 272:1997;25576-25582
12. Duchateau P.N., Movsesyan I., Yamashita S., Sakai N., Hirano K., Schoenhaus S.A., O'Connor-Kearns P.M., Spencer S.J., Jaffe R.B., Redberg R.F., Ishida B.Y., Matsuzawa Y., Kane J.P., Malloy M.J. Plasma apolipoprotein L concentrations correlate with plasma triglycerides and cholesterol levels in normolipidemic, hyperlipidemic, and diabetic subjects. J. Lipid Res. 41:2000;1231-1236
13. Duchateau P.N., Pullinger C.R., Cho M.H., Eng C., Kane J.P. Apolipoprotein L gene family: tissue-specific expression, splicing, promoter regions; discovery of a new gene. J. Lipid Res. 42:2001;620-630
14. Garcia-Salcedo J.A., Pérez-Morga D., Gijon P., Dilbeck V., Pays E., Nolan D.P. A differential role for actin during the life cycle of Trypanosoma brucei. Eur. Mol. Biol. Org. J. 23:(4):2004;780-789
15. Gibson W.C. Will the real Trypanosoma brucei gambiense please stand up? Parasitol. Today. 2:1986;255-257
16. Gibson W. Will the real Trypanosoma brucei rhodesiense please step forward? Trends Parasitol. 18:2002;486-490
17. Gibson W. Epidemiology and diagnosis of African trypanosomiasis using DNA probes. Trans. R. Soc. Trop. Med. Hyg. 96:(Suppl. 1):2002;S141-S143
18. Gibson W., Ferris V. Conservation of the genomic location of the human serum resistance associated gene in Trypanosoma brucei rhodesiense. Mol. Biochem. Parasitol. 130:2003;159-162
19. Gibson W., Backhouse T., Griffiths A. The human serum resistance associated gene is ubiquitous and conserved in Trypanosoma brucei rhodesiense throughout East Africa. Infect. Genet. Evol. 1:2002;207-214
20. Gillett M.P., Owen J.S. Trypanosoma brucei brucei: differences in the trypanocidal activity of human plasma and its relationship to the level of high density lipoproteins. Trans. R. Soc. Trop. Med. Hyg. 85:1991;612-616
21. Gillett M.P., Owen J.S. Characteristics of the binding of human and bovine high-density lipoproteins by bloodstream forms of the African trypanosome, Trypanosoma brucei brucei. Biochim. Biophys. Acta. 1123:1992;239-248
22. Gillett M.P., Owen J.S. Comparison of the cytolytic effects in vitro on Trypanosoma brucei brucei of plasma, high density lipoproteins, and apolipoproteinA-I from hosts both susceptible (cattle and sheep) and resistant (human and baboon) to infection. J. Lipid Res. 33:1992;513-523
23. Green H.P., Del Pilar Molina Portela M., St Jean E.N., Lugli E.B., Raper J. Evidence for a Trypanosoma brucei lipoprotein scavenger receptor. J. Biol. Chem. 278:2003;422-427
24. Gull K. Host-parasite interactions and trypanosome morphogenesis: a flagellar pocketful of goodies. Curr. Op. Microbiol. 6:2003;365-370
25. Hager K.M., Hajduk S.L. Mechanism of resistance of African trypanosomes to cytotoxic human HDL. Nature. 385:1997;823-826
26. Hager K.M., Pierce M.A., Moore D.R., Tytler E.M., Esko J.D., Hajduk S.L. Endocytosis of a cytotoxic human high density lipoprotein results in disruption of acidic intracellular vesicles and subsequent killing of African trypanosomes. J. Cell Biol. 126:1994;155-167
27. Hajduk S.L., Moore D.R., Vasudevacharya J., Siqueira H., Torri A.F., Tytler E.M., Esko J.D. Lysis of Trypanosoma brucei by a toxic subspecies of human high-density lipoprotein. J. Biol. Chem. 264:1989;5210-5217
28. Hajduk S.L., Hager K.M., Esko J.D. Human high density lipoprotein killing of African trypanosomes. Annu. Rev. Microbiol. 48:1994;139-162
29. Hatada S., Seed J.R., Barker C., Hajduk S.L., Black S., Maeda N. No trypanosome lytic activity in the sera of mice producing human haptoglobin-related protein. Mol. Biochem. Parasitol. 119:2002;291-294
30. Hide G., Cattand P., Le Ray D., Barry J.D., Tait A. The identification of Trypanosoma brucei subspecies using repetitive DNA sequences. Mol. Biochem. Parasitol. 39:1990;213-225
31. Horrevoets A.J., Fontijn R.D., van Zonneveld A.J., de Vries C.J., ten Cate J.W., Pannekoek H. Vascular endothelial genes that are responsive to tumor necrosis factor-alpha in vitro are expressed in atherosclerotic lesions, including inhibitor of apoptosis protein-1, stannin, and two novel genes. Blood. 93:1999;3418-3431
32. Kageruka P., Magnus E., Bajyana Songa E., Nantulya V., Jochems M., Hamers R. Infectivity of Trypanosoma (Trypanozoon) brucei gambiense for baboons (Papio hamadryas, Papio papio). Ann. Soc. Belge Méd. Trop. 71:1991;39-45
33. Laveran A., Mesnil F. Masson, Cie. Trypanosomes et Trypanosomiases. 1912
34. Levine D.M., Parker T.S., Donnelly T.M., Walsh A., Rubin A.L. In vivo protection against endotoxin by plasma high density lipoprotein. Proc. Natl Acad. Sci. USA. 90:1993;12040-12044
35. Lorenz P., Barth P.E., Rudin W., Betschart B. Importance of acidic intracellular compartments in the lysis of Trypanosoma brucei brucei by normal human serum. Trans. R. Soc. Trop. Med. Hyg. 88:1994;487-488
36. Lorenz P., James R.W., Owen J.S., Betschart B. Heterogeneity in the properties of the trypanolytic factor in normal human serum. Mol. Biochem. Parasitol. 64:1994;153-164
37. Lorenz P., Betschart B., Owen J.S. Trypanosoma brucei brucei and high density lipoproteins: old and new thoughts on the identity and mechanism of the trypanocidal factor in human serum. Parasitol. Today. 11:1995;348-352
38. Lorenz P., Owen J.S., Hassall D.G. Human serum resistant Trypanosoma brucei rhodesiense accumulates similar amounts of fluorescently-labelled trypanolytic human HDL3 particles as human serum sensitive T.b. brucei. Mol. Biochem. Parasitol. 74:1995;113-118
39. MacLeod A., Tweedie A., Welburn S.C., Maudlin I., Turner C.M., Tait A. Minisatellite marker analysis of Trypanosoma brucei: reconciliation of clonal, panmictic, and epidemic population genetic structures. Proc. Natl Acad. Sci. USA. 97:2000;13442-13447
40. MacLeod A., Tait A., Turner C.M. The population genetics of Trypanosoma brucei and the origin of human infectivity. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 356:2001;1035-1044
41. Marx C.E., Jarskog L.F., Lauder J.M., Lieberman J.A., Gilmore J.H. Cytokine effects on cortical neuron MAP-2 immunoreactivity: implications for schizophrenia. Biol. Psychiatry. 50:2001;743-749
42. McEvoy S.M., Maeda N. Complex events in the evolution of the haptoglobin gene cluster in primates. J. Biol. Chem. 263:1988;15740-15747
43. Milner J.D., Hajduk S.L. Expression and localization of serum resistance associated protein in Trypanosoma brucei rhodesiense. Mol. Biochem. Parasitol. 104:1999;271-283
44. Mimmack M.L., Ryan M., Baba H., Navarro-Ruiz J., Iritani S., Faull R.L., McKenna P.J., Jones P.B., Arai H., Starkey M., Emson P.C., Bahn S. Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22. Proc. Natl Acad. Sci. USA. 99:2002;4680-4685
45. Molina Portela M.P., Raper J., Tomlinson S. An investigation into the mechanism of trypanosome lysis by human serum factors. Mol. Biochem. Parasitol. 110:2000;273-282
46. Monajemi H., Fontijn R.D., Pannekoek H., Horrevoets A.J. The apolipoprotein L gene cluster has emerged recently in evolution and is expressed in human vascular tissue. Genomics. 79:2002;539-546
47. Moore D.R., Smith A., Hager K.M., Waldon R., Esko J.D., Hajduk S.L. Developmentally regulated sensitivity of Trypanosoma brucei brucei to the cytotoxic effects of human high-density lipoprotein. Exp. Parasitol. 81:1995;216-226
48. Muranjan M., Nussenzweig V., Tomlinson S. Characterization of the human serum trypanosome toxin, haptoglobin-related protein. J. Biol. Chem. 273:1998;3884-3887
49. Naudin J., Capo C., Giusano B., Mege J.L., Azorin J.M. A differential role for interleukin-6 and tumor necrosis factor-alpha in schizophrenia? Schizophr. Res. 26:1997;227-233
50. Nilsson-Ehle I., Nilsson-Ehle P. Changes in plasma lipoproteins in acute malaria. J. Intern. Med. 227:1990;151-155
51. Ortiz-Ordonez J.C., Sechelski J.B., Seed J.R. Mechanism of lysis of Trypanosoma brucei gambiense by human serum. J. Parasitol. 80:1994;924-930
52. Owen J.S., Gillett M.P., Hughes T.E. Transgenic mice expressing human apolipoprotein A-I have sera with modest trypanolytic activity in vitro but remain susceptible to infection by Trypanosoma brucei brucei. J. Lipid Res. 33:1992;1639-1646
53. Owens B.J., Anantharamaiah G.M., Kahlon J.B., Srinivas R.V., Compans R.W., Segrest J.P. Apolipoprotein A-I and its amphipathic helix peptide analogues inhibit human immunodeficiency virus-induced syncytium formation. J. Clin. Invest. 86:1990;1142-1150
54. Page N.M., Butlin D.J., Lomthaisong K., Lowry P.J. The human apolipoprotein L gene cluster: identification, classification, and sites of distribution. Genomics. 74:2001;71-78
55. Pays E., Lips S., Nolan D., Vanhamme L., Perez-Morga D., The V.S.G. expression sites of Trypanosoma brucei: multipurpose tools for the adaptation of the parasite to mammalian hosts. Mol. Biochem. Parasitol. 114:2001;1-16
56. Poelvoorde P., Vanhamme L., Van Den Abbeele J., Switzer W.M., Pays E. Distribution of apolipoprotein L-I and trypanosome lytic activity among primate sera. Mol. Biochem. Parasitol. 134:2004;155-157
57. Radwanska M., Chamekh M., Vanhamme L., Claes F., Magez S., Magnus E., De Baetselier P., Büscher P., Pays E. The serum resistance-associated gene as a diagnostic tool for the detection of Trypanosoma brucei rhodesiense. Am. J. Trop. Med. Hyg. 67:2002;684-690
58. Raper J., Nussenzweig V., Tomlinson S. Lack of correlation between haptoglobin concentration and trypanolytic activity of normal human serum. Mol. Biochem. Parasitol. 76:1996;337-338
59. Raper J., Nussenzweig V., Tomlinson S. The main lytic factor of Trypanosoma brucei brucei in normal human serum is not high density lipoprotein. J. Exp. Med. 183:1996;1023-1029
60. Raper J., Fung R., Ghiso J., Nussenzweig V., Tomlinson S. Characterization of a novel trypanosome lytic factor from human serum. Infect. Immun. 67:1999;1910-1916
61. Raper J., Portela M.P., Lugli E., Frevert U., Tomlinson S. Trypanosome lytic factors: novel mediators of human innate immunity. Curr. Opin. Microbiol. 4:2001;402-408
62. Rifkin M.R. Identification of the trypanocidal factor in normal human serum: high density lipoprotein. Proc. Natl Acad. Sci. USA. 75:1978;3450-3454
63. Rifkin M.R. Trypanosoma brucei: biochemical and morphological studies of cytotoxicity caused by normal human serum. Exp. Parasitol. 58:1984;81-93
64. Rifkin M.R. Trypanosoma brucei: cytotoxicity of host high-density lipoprotein is not mediated by apolipoprotein A-I. Exp. Parasitol. 72:1991;216-218
65. Seed J.R., Sechelski J.B., Loomis M.R. A survey for a trypanocidal factor in primate sera. J. Protozool. 37:1990;393-400
66. Shimamura M., Hager K.M., Hajduk S.L. The lysosomal targeting and intracellular metabolism of trypanosome lytic factor by Trypanosoma brucei brucei. Mol. Biochem. Parasitol. 115:2001;227-237
67. Smith A.B., Esko J.D., Hajduk S.L. Killing of trypanosomes by the human haptoglobin-related protein. Science. 268:1995;284-286
68. Smith A.B., Hajduk S.L. Identification of haptoglobin as a natural inhibitor of trypanocidal activity in human serum. Proc. Natl Acad. Sci. USA. 92:1995;10262-10266
69. Sorensen O., Bratt T., Johnsen A.H., Madsen M.T., Borregaard N. The human antibacterial cathelicidin, hCAP-18, is bound to lipoproteins in plasma. J. Biol. Chem. 274:1999;22445-22451
70. Tomlinson S., Jansen A.M., Koudinov A., Ghiso J.A., Choi-Miura N.H., Rifkin M.R., Ohtaki S., Nussenzweig V. High-density-lipoprotein-independent killing of Trypanosoma brucei by human serum. Mol. Biochem. Parasitol. 70:1995;131-138
71. Tomlinson S., Muranjan M., Nussenzweig V., Raper J. Haptoglobin-related protein and apolipoprotein AI are components of the two trypanolytic factors in human serum. Mol. Biochem. Parasitol. 86:1997;117-120
72. Vanhamme L., Paturiaux-Hanocq F., Poelvoorde P., Nolan D.P., Lins L., Van Den Abbeele J., Pays A., Tebabi P., Van Xong H., Jacquet A., Moguilevsky N., Dieu M., Kane J.P., De Baetselier P., Brasseur R., Pays E. Apolipoprotein L-I is the trypanosome lytic factor of human serum. Nature. 422:2003;83-87
73. Vanhamme L., Pays E., McCulloch R., Barry J.D. An update on antigenic variation in African trypanosomes. Trends Parasitol. 17:2001;338-343
74. Vanhamme L., Renauld H., Lecordier L., Poelvoorde P., Abbeele J., Pays E. The Trypanosoma brucei reference strain TREU927/4 contains T.b. rhodesiense-specific SRA sequences, but displays a distinct phenotype of relative resistance to human serum. Mol. Biochem. Parasitol. 2004;. 135, 39-47
75. Van Lenten B.J., Wagner A.C., Nayak D.P., Hama S., Navab M., Fogelman A.M. High-density lipoprotein loses its anti-inflammatory properties during acute influenza A infection. Circulation. 103:2001;2283-2288
76. Van Meirvenne N., Magnus E., Janssens P.G. The effect of normal human serum on trypanosomes of distinct antigenic type (ETat 1 to 12) isolated from a strain of Trypanosoma brucei rhodesiense. Ann. Soc. Belg. Med. Trop. 56:1976;55-63
77. Vassella E., Reuner B., Yutzy B., Boshart M. Differentiation of African trypanosomes is controlled by a density sensing mechanism which signals cell cycle arrest via the cAMP pathway. J. Cell Sci. 110:1997;2661-2671
78. Welburn S.C., Odiit M. Recent developments in human African trypanosomiasis. Curr. Opin. Infect. Dis. 15:2002;477-484
79. Welburn S.C., Picozzi K., Fevre E.M., Coleman P.G., Odiit M., Carrington M., Maudlin I. Identification of human-infective trypanosomes in animal reservoir of sleeping sickness in Uganda by means of serum-resistance-associated (SRA) gene. Lancet. 358:2001;2017-2019
80. Xong H.V., Vanhamme L., Chamekh M., Chimfwembe C.E., Van Den Abbeele J., Pays A., Van Meirvenne N., Hamers R., De Baetselier P., Pays E. A VSG expression site-associated gene confers resistance to human serum in Trypanosoma rhodesiense. Cell. 95:1998;839-846